Transcranial Direct Current Stimulation on Singers Voice
Effect of Transcranial Direct Current Stimulation on Singers' Voice
1 other identifier
interventional
45
1 country
1
Brief Summary
Transcranial direct current stimulation (tDCS) can be used to temporarily and reversibly modulate brain functions and is an increasingly utilized tool to investigate the relationships between brain and behavior. This study aimed to identify the effects of tDCS on vocal quality, vocal range, neuromotor functioning of the larynx and self-reported vocal effort in vocally healthy singers. This is a triple-blinded, sham-controlled, randomized clinical trial. The participants were randomized to one of the three tDCS groups (primary motor cortex, cerebellum or sham). In each group a voice training was applied at the same tDCS time. The three groups are: (i) cerebellum; (ii) primary motor cortex (M1); (iii) sham. The tDCS parameters in the active groups are anodal - 2mA for 20 minutes, at the sham group the stimuli are finished 30 secondes before starting. Volunteers passed for 10 intervention days and they were evaluated for vocal performance before the sessions, in the day 5 of intervention, the last day of intervention (day 10) and 1 month later for follow up evaluation. Voice recordings was taken to assess the following vocal parameters: vocal range profile (VRP) at weak and strong intensities; vocal quality (jitter, shimmer, irregularity, glottal-to-noise excitation ratio, CPPS,HNR, and dysphonia acoustic index) at weak, habitual, and strong intensities; laryngeal diadochokinesis, and self-reported vocal effort using the adapted Borg CR10 scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2024
CompletedFirst Submitted
Initial submission to the registry
September 21, 2024
CompletedFirst Posted
Study publicly available on registry
September 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2025
CompletedMay 7, 2026
May 1, 2026
1.6 years
September 21, 2024
May 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vocal Range Profile
Minimum fundamental frequency - f0; Maximum f0; Extension f0; Extension in Semitone; Minimum intensity; Maximum intensity and Area
From enrollment to the end of evaluation at 6 weeks
Secondary Outcomes (1)
Vocal quality
From enrollment to the end of evaluation at 6 weeks
Other Outcomes (2)
Larynx neuromuscular control and coordination
From enrollment to the end of evaluation at 6 weeks
Self-reported vocal effort
From enrollment to the end of evaluation at 6 weeks
Study Arms (3)
M1 and vocal exercise
EXPERIMENTALanodal tDCS over primary motor cortex associated with the vocal exercise using the flexible tube in water.
Cerebellum and vocal exercise
ACTIVE COMPARATORanodal tDCS over cerebellum associated with the vocal exercise using the flexible tube in water.
Sham and vocal exercise
PLACEBO COMPARATORtDCS sham associated with the vocal exercise using the flexible tube in water.
Interventions
The tDCS is a non-invasive brain stimulation technique. In this study, we used an intensity of 2mA for 20 minutes in two different areas. M1 group: the anode was over C5 (10-10 EEG system) and the cathode was placed over Fp2. For the Cerebellum group stimulation, the targeted anode area was 2 cm below the inion and the cathode over the deltoid muscle.
The exercise involved producing sustained /u/ vowels in ascending and descending scales, tailored to each participants vocal range. The flexible tube was 35 cm long, 1 cm in diameter, and 2 mm thick. One end of the tube was submerged 3 cm into a 500 ml bottle filled with water. Participants produced four sets of vocal exercises, each lasting 3 minutes, with 2-minute rests between sets, totaling 20 minutes of vocal therapy.
Eligibility Criteria
You may qualify if:
- Vocally healthy singers without formal singing education
You may not qualify if:
- Smokers
- Abnormalities in previous screening for voice symptoms
- Exhibited signs and symptoms of laryngeal, pharyngeal, or respiratory diseases at the time of collection
- Used neuroactive medications
- Had metallic implants in the cervical region or above
- Had any history of seizures or epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal de Pernambuco
Recife, Pernambuco, 50740-560, Brazil
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 21, 2024
First Posted
September 25, 2024
Study Start
March 11, 2024
Primary Completion
October 10, 2025
Study Completion
December 20, 2025
Last Updated
May 7, 2026
Record last verified: 2026-05